John G Hanly

John G Hanly

UNVERIFIED PROFILE

Are you John G Hanly?   Register this Author

Register author
John G Hanly

John G Hanly

Publications by authors named "John G Hanly"

Are you John G Hanly?   Register this Author

83Publications

2448Reads

-Profile Views

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Review: Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions.

Arthritis Rheumatol 2019 Jan 24;71(1):33-42. Epub 2018 Nov 24.

Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.40591
Publisher Site
http://dx.doi.org/10.1002/art.40591DOI Listing
January 2019

Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.

J Autoimmun 2019 Jan 30;96:59-73. Epub 2018 Aug 30.

Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY, USA; Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2018.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310639PMC
January 2019

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

J Rheumatol 2018 Oct 1;45(10):1426-1439. Epub 2018 Sep 1.

From the Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Division of Rheumatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Canadian Arthritis Patient Alliance; Division of Rheumatology, Department of Medicine, McGill University; Division of Rheumatology, Department of Medicine, Université de Montréal, Montreal; Division of Rheumatology, Department of Medicine, Université Laval, Quebec City, Quebec; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario; Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia; Division of Rheumatology, Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario; Division of Rheumatology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba; General Internal Medicine, McGill University Health Centre, McGill University, Montreal, Quebec; Cochrane Musculoskeletal Group, University of Ottawa, Ottawa; Division of Rheumatology, Department of Medicine, Western University, London, Ontario; Canadian Agency for Drugs and Technologies in Health, Ottawa; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton; Centre for Practice-changing Research, Ottawa Hospital Research Institute, Ottawa, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171459DOI Listing
October 2018

Managing premature atherosclerosis in patients with chronic inflammatory diseases.

CMAJ 2018 Apr;190(14):E430-E439

Department of Medicine (Legge); Division of Rheumatology, Department of Medicine, and Department of Pathology (Hanly), Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.170776DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893318PMC
April 2018

Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.

J Rheumatol 2018 Mar 15;45(3):393-396. Epub 2018 Jan 15.

From The Research Institute of the McGill University Health Centre, Montreal; Université de Laval, Service de rheumatologie, Quebec City, Quebec; Toronto Western Hospital, Toronto, Ontario; Dalhousie University and Capital Health, Halifax, Nova Scotia; University of Manitoba, Winnipeg, Manitoba; Division of Rheumatology, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada; Northwestern University Feinberg School of Medicine, Chicago, Illinois; Johns Hopkins University School of Medicine, Baltimore, Maryland; University of California at San Francisco, Department of Medicine, San Francisco, California; State University of New York-Downstate Medical Center, Brooklyn; The Feinstein Institute for Medical Research, Manhasset, New York; Therapeutic Radiology, Yale University, New Haven, Connecticut, USA; University of Birmingham, College of Medical and Dental Sciences, Birmingham; University College London, Faculty of Medicine, Department of Rheumatology, London, UK; Lund University Hospital, Lund, Sweden; The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834350PMC
March 2018

Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.

J Rheumatol 2017 Dec 15;44(12):1859-1866. Epub 2017 Sep 15.

From the Division of Rheumatology, Department of Medicine, and the Department of Diagnostic Imaging, and the Division of Anatomic Pathology, Department of Pathology and Laboratory Medicine, and the Division of Vascular Surgery, Department of Surgery, Queen Elizabeth II Health Sciences Centre, Nova Scotia Health Authority; Dalhousie University, Halifax; Department of Radiology, Valley Regional Hospital, Kentville, Nova Scotia; Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170138DOI Listing
December 2017

Physical activity and sedentary behavior in patients with systemic lupus erythematosus and rheumatoid arthritis.

Open Access Rheumatol 2017 8;9:191-200. Epub 2017 Nov 8.

Division of Rheumatology, Department of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OARRR.S148376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687492PMC
November 2017

A Longitudinal Study of Ambulatory Physician Encounters, Emergency Room Visits, and Hospitalizations by Patients with Rheumatoid Arthritis: A 13-year Population Health Study.

J Rheumatol 2017 Oct 1;44(10):1421-1428. Epub 2017 Aug 1.

From the Division of Rheumatology, Department of Medicine, and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University; Department of Medicine and Research Methods Unit, Queen Elizabeth II Health Sciences Centre and Dalhousie University; Atlantic Clinical Cancer Research Unit, Capital Health, Halifax; Nova Scotia, Canada; Health Economics Group, Norwich Medical School, University of East Anglia, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170056DOI Listing
October 2017

Utilization of Ambulatory Physician Encounters, Emergency Room Visits, and Hospitalizations by Systemic Lupus Erythematosus Patients: A 13-Year Population Health Study.

Arthritis Care Res (Hoboken) 2016 08;68(8):1128-34

Capital Health, Halifax, Nova Scotia, Canada, and Norwich Medical School, University of East Anglia, Norwich, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22808DOI Listing
August 2016

A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.

Hum Pathol 2016 06 2;52:190-6. Epub 2016 Mar 2.

Research Unit Dermatopathology, Department of Dermatology, Medical University of Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2016.02.002DOI Listing
June 2016

Measuring the Rheumatology Workforce in Canada: A Literature Review.

J Rheumatol 2016 06 1;43(6):1121-9. Epub 2016 Apr 1.

From the Department of Community Health Sciences, Cumming School of Medicine, and the Division of Rheumatology, Department of Medicine, and McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta; Toronto Western Research Institute, University of Toronto, Toronto, Ontario; Dalhousie University, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Division of Pediatric Rheumatology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton; Division of Rheumatology, University of Western Ontario, London, Ontario, Canada.J. Brophy, MD, FRCPC, rheumatologist in private practice, Guelph, Ontario, Canada; D.A. Marshall, PhD, Professor, Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, McCaig Institute for Bone and Joint Health; E.M. Badley, PhD, Toronto Western Research Institute, University of Toronto; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University, attending staff rheumatologist, Queen Elizabeth II Health Sciences Center; H. Averns, MB, ChB, FRCP ( UK), FRCPC, rheumatologist in private practice, Kingston, Ontario, Canada; J. Ellsworth, MD, FRCPC, Professor and Head, Division of Pediatric Rheumatology, Faculty of Medicine and Dentistry, University of Alberta; J.E. Pope, MD, MPH, FRCPC, Professor of Medicine, Division of Rheumatology, University of Western Ontario; C.E. Barber, MD, PhD, FRCPC, Assistant Professor, Division of Rheumatology, Department of Medicine, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151174DOI Listing
June 2016

Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.

J Rheumatol 2016 06 15;43(6):1050-6. Epub 2016 Apr 15.

From the Division of Rheumatology, Department of Medicine, and Department of Pathology, Nova Scotia Health Authority, Dalhousie University; Research Methods Unit, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.A. Legge, MD, Department of Medicine, Nova Scotia Health Authority, Dalhousie University; S. Doucette, MSc, Research Methods Unit, Nova Scotia Health Authority; J.G. Hanly, MD, FRCPC, Division of Rheumatology, Department of Medicine, and Department of Pathology, Nova Scotia Health Authority, Dalhousie University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150985DOI Listing
June 2016

The Longterm Effect of Early Intensive Treatment of Seniors with Rheumatoid Arthritis: A Comparison of 2 Population-based Cohort Studies on Time to Joint Replacement Surgery.

J Rheumatol 2016 05 15;43(5):861-8. Epub 2016 Feb 15.

From the Department of Epidemiology, Biostatistics and Occupational Health, McGill University; Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre; École de Réadaptation, Université de Montréal, Montreal; Department of Medicine, Université de Sherbrooke, Sherbrooke; Division of Rheumatology, Department of Medicine, Centre de recherche du CHU de Québec, Université Laval, Quebec City, Quebec; Institute for Clinical Evaluative Sciences, University of Toronto; Institute of Health Policy, Management and Evaluation; Division of Rheumatology, University of Toronto, Toronto; Department of Family Medicine, McMaster University, Hamilton, Ontario; Division of Rheumatology, Departments of Medicine and Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.J. Widdifield, PhD, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, and Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, and Institute for Clinical Evaluative Sciences; C.S. Moura, PhD, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, and Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre; Y. Wang, PhD(c), Department of Epidemiology, Biostatistics and Occupational Health, McGill University; M. Abrahamowicz, PhD, Department of Epidemiology, Biostatistics and Occupational Health, McGill University; J.M. Paterson, MSc, Institute for Clinical Evaluative Sciences, and University of Toronto, Institute of Health Policy, Management and Evaluation, and Department of Family Medicine, McMaster University; A. Huang, MSc, Institute for Clinical Evaluative Sciences; M.E. Beauchamp, PhD, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre; G. Boire, MD, FRCPC, MSc, Department of Medicine, Université de Sherbrooke; P.R. Fortin, MD, FRCPC, MPH, Division of Rheumatology, Department of Medic

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151156DOI Listing
May 2016

The use of administrative health care databases to identify patients with rheumatoid arthritis.

Open Access Rheumatol 2015 6;7:69-75. Epub 2015 Nov 6.

Atlantic Clinical Cancer Research Unit, Capital Health, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OARRR.S92630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045118PMC
November 2015

Adherence to guidelines and the screening tool of older persons' potentially inappropriate prescriptions criteria for colchicine dosing for gout treatment in beneficiaries of the Nova Scotia Seniors' Pharmacare Program.

Clin Ther 2015 Oct 29;37(10):2339-46. Epub 2015 Sep 29.

Division of Rheumatology, Nova Scotia Rehabilitation Centre, Capital Health, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2015.08.016DOI Listing
October 2015

Attribution in the assessment of nervous system disease in SLE.

Authors:
John G Hanly

Rheumatology (Oxford) 2015 May 5;54(5):755-6. Epub 2014 Dec 5.

Medicine, Division of Rheumatology and Department of Pathology, Dalhousie University, 1341 Summer Street, Halifax, Nova Scotia and Capital Health, Halifax, Nova Scotia, Canada Medicine, Division of Rheumatology and Department of Pathology, Dalhousie University, 1341 Summer Street, Halifax, Nova Scotia and Capital Health, Halifax, Nova Scotia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keu458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416085PMC
May 2015

Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.

Arthritis Care Res (Hoboken) 2015 Mar;67(3):431-6

McGill University Health Centre, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22452DOI Listing
March 2015

Plasmacytoid dendritic cells in hypertrophic discoid lupus erythematosus: an objective evaluation of their diagnostic value.

J Cutan Pathol 2015 Jan 15;42(1):32-8. Epub 2014 Dec 15.

Department of Pathology, Capital District Health Authority and Dalhousie University, Halifax, NS, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12416DOI Listing
January 2015

Reply: To PMID 24166793.

Authors:
John G Hanly

Arthritis Rheumatol 2014 Oct;66(10):2912-3

Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada; for the Systemic Lupus International Collaborating Clinics.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.38766DOI Listing
October 2014

Diagnosis and management of neuropsychiatric SLE.

Authors:
John G Hanly

Nat Rev Rheumatol 2014 Jun 11;10(6):338-47. Epub 2014 Feb 11.

Division of Rheumatology, Department of Medicine and Department of Pathology, Capital Health and Dalhousie University, Halifax, NS B3H 4K4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2014.15DOI Listing
June 2014

American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.

J Rheumatol 2014 May 1;41(5):875-80. Epub 2014 Apr 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Rheumatology, Hospital for Rheumatic Diseases and Hanyang University Medical Center, Seoul, Korea; Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Montreal General Hospital and McGill University Health Centre, Montreal, Quebec, Canada; Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Quebec, Canada; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada; Centre for Rheumatology Research, University College, London, UK; Cedars-Sinai/David Geffen School of Medicine, University of California, Los Angeles, California, USA; Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA; Department of Rheumatology, University Hospital Lund, Lund, Sweden; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA; Center for Rheumatology Research, Landspitali University Hospital, Reyjkavik, Iceland; Northwestern University and Feinber

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130704DOI Listing
May 2014

Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.

J Rheumatol 2014 Apr 1;41(4):673-9. Epub 2014 Mar 1.

From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130667DOI Listing
April 2014

Reply: To PMID 24166793.

Authors:
John G Hanly

Arthritis Rheumatol 2014 Apr;66(4):1059-60

Queen Elizabeth II Health Sciences Centre, and Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.38332DOI Listing
April 2014

Broken livedo: clue to a systemic disease.

Am J Dermatopathol 2012 Oct;34(7):755-6, 770-1

Dalhousie University, Faculty of Medicine, Dalhousie University and Capital District Health Authority, Halifax, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0b013e3182487430DOI Listing
October 2012

Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.

Autoimmun Rev 2012 Jul 11;11(9):642-5. Epub 2011 Nov 11.

INOVA Diagnostics, INC. San Diego, CA 32131-1638, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2011.11.005DOI Listing
July 2012

Screening for cognitive impairment in systemic lupus erythematosus.

J Rheumatol 2012 Jul 1;39(7):1371-7. Epub 2012 Jun 1.

Division of Rheumatology, Nova Scotia Rehabilitation Centre, 2nd Floor, 1341 Summer Street, Halifax, Nova Scotia B3H 4K4, Canada..

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.111504DOI Listing
July 2012

The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases.

J Rheumatol 2011 Aug 1;38(8):1612-6. Epub 2011 May 1.

Division of Clinical Epidemiology, Department of Medicine, McGill University Health Centre (MUHC), Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.101149DOI Listing
August 2011

Diagnosis of cognitive impairment in adult and pediatric SLE.

Nat Rev Rheumatol 2011 Aug 23;7(10):564-5. Epub 2011 Aug 23.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrrheum.2011.127
Publisher Site
http://dx.doi.org/10.1038/nrrheum.2011.127DOI Listing
August 2011

Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole.

J Cutan Pathol 2010 Dec 25;37(12):1212-9. Epub 2010 Aug 25.

Department of Pathology, Capital District Health Authority and Dalhousie University, 5788 University Avenue, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0560.2010.01613.xDOI Listing
December 2010

Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.

J Immunol Methods 2010 Jun 9;358(1-2):75-80. Epub 2010 May 9.

Division of Rheumatology, Capital Health and Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2010.04.005DOI Listing
June 2010

Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.

J Immunol Methods 2010 Jan 20;352(1-2):147-52. Epub 2009 Oct 20.

Division of Rheumatology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2009.10.003DOI Listing
January 2010

Demystifying neuropsychiatric lupus--is it possible?

Authors:
John G Hanly

Bull NYU Hosp Jt Dis 2009 ;67(3):276-80

Division of Rheumatology, Department of Medicine and Department of Pathology, Capital Health and Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
January 2010

Impact of a rheumatology consultation service on the diagnostic accuracy and management of gout in hospitalized patients.

J Rheumatol 2009 Aug 30;36(8):1699-704. Epub 2009 Jun 30.

Division of Rheumatology, Nova Scotia Rehabilitation Centre, Halifax, Nova Scotia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.081296DOI Listing
August 2009

Prospective study of neuropsychiatric events in systemic lupus erythematosus.

J Rheumatol 2009 Jul 15;36(7):1449-59. Epub 2009 May 15.

Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia B3H 4K4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.081133DOI Listing
July 2009

Gout in the elderly--a population health study.

J Rheumatol 2009 Apr 13;36(4):822-30. Epub 2009 Mar 13.

Division of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Centre, College of Pharmacy, Dalhousie University, Halifax, Nova Scotia B3H 4K4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.080768DOI Listing
April 2009

Cognitive dysfunction in systemic lupus erythematosus: past, present, and future.

Arthritis Rheum 2008 Nov;58(11):3286-98

National Jewish Medical and Research Center, Denver, Colorado 80206, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.23991
Publisher Site
http://dx.doi.org/10.1002/art.23991DOI Listing
November 2008

New insights into central nervous system lupus: a clinical perspective.

Authors:
John G Hanly

Curr Rheumatol Rep 2007 May;9(2):116-24

Division of Rheumatology, Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada, B3H 4K4.

View Article

Download full-text PDF

Source
May 2007

Insight into SLE-related migraine using brain single-photon-emission computed tomography.

Nat Clin Pract Rheumatol 2007 Apr 20;3(4):200-1. Epub 2007 Feb 20.

Division of Rheumatology, Department of Medicine, at Dalhousie University and Queen Elizabeth II Health Sciences Center in Halifax, NS, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0453DOI Listing
April 2007

Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.

J Rheumatol 2006 Aug;33(8):1553-8

Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
August 2006

Meningeal involvement in Wegener's granulomatosis.

J Rheumatol 2006 Feb;33(2):364-7

Division of Rheumatology, Department of Medicine, the Division of Anatomical Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
February 2006

Tribute: John Francis Lydiard "Jack" Woodbury.

Authors:
John G Hanly

J Rheumatol 2006 Feb;33(2):368

Division of Rheumatology, Arthritis Centre of Nova Scotia, Canada.

View Article

Download full-text PDF

Source
February 2006

Management of neuropsychiatric lupus.

Best Pract Res Clin Rheumatol 2005 Oct;19(5):799-821

Division of Rheumatology, Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada B3H 4K4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.berh.2005.04.003DOI Listing
October 2005

Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.

J Rheumatol 2005 Aug;32(8):1459-6

Division of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
August 2005

Neuropsychiatric lupus.

Authors:
John G Hanly

Rheum Dis Clin North Am 2005 May;31(2):273-98, vi

Division of Rheumatology, Arthritis Center of Nova Scotia, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS B3H 4K4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2005.01.007DOI Listing
May 2005

Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.

J Rheumatol 2004 Nov;31(11):2156-62

Division of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
November 2004

Physician resources and postgraduate training in canadian academic rheumatology centers: a 5-year prospective study.

Authors:
John G Hanly

J Rheumatol 2004 Jun;31(6):1200-5

Canadian Council of Academic Rheumatologists and Dalhousie University, Halifax, Canada.

View Article

Download full-text PDF

Source
June 2004

Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis.

J Rheumatol 2003 Sep;30(9):1990-3

Divisions of Rheumatology and Hematology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, 1341 Summer Street, Halifax, Nova Scotia, Canada B3H 4K4.

View Article

Download full-text PDF

Source
September 2003

Antiphospholipid syndrome: an overview.

Authors:
John G Hanly

CMAJ 2003 Jun;168(13):1675-82

Division of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC161613PMC
June 2003

Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: lack of evidence for a direct role of lamin B1 in apoptotic blebs.

Arthritis Rheum 2002 Oct;46(10):2695-707

Autoimmunity Research Laboratory, Notre-Dame Hospital, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec H2L 4M1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.10552DOI Listing
October 2002

Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.

J Rheumatol 2002 Aug;29(8):1683-8

Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
August 2002